MPN Watch

Dossier web other 06-jan-2026

MPN Research Foundation Opens 2026 MPN Challenge Funding Cycle

Key claim: The MPN Research Foundation has opened its 2026 MPN Challenge funding cycle, offering $200,000 two-year grants across projects including SLAMF7 immunotherapy, CAR-T for myelofibrosis, antibody responses, neutrophil biomarkers, and AI-based bone marrow assessment.

Abstract

MPN Research Foundation (MPNRF) announced opening of the MPN Challenge funding cycle as of January 6, 2026, offering two-year grants totaling $200,000. Projects span immunotherapy for SLAMF7, CAR-T approaches for myelofibrosis, anti-cancer antibody responses, neutrophil biomarkers for disease progression, and AI-based bone marrow assessment tools.

Why this matters

Pending synthesis.

Source

Link

Briefing card

MPN Research Foundation Opens 2026 MPN Challenge Funding Cycle
Stage: other · web · 06-jan-2026

The MPN Research Foundation has opened its 2026 MPN Challenge funding cycle, offering $200,000 two-year grants across projects including SLAMF7 immunotherapy, CAR-T for myelofibrosis, antibody responses, neutrophil biomarkers, and AI-based bone marrow assessment.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: url:https://mpnresearchfoundation.org/mpn-challenge/

Ask about this finding

Replies are grounded in the abstract and metadata above. The model will quote directly when possible and say so if a question isn't covered.

build build 612 · 69ce4cf-dirty · 2026-11-11